MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2147/jir.s292544

Медицинская библиотека · Journal of inflammation research · 2021

Clinical Implications of Intestinal Barrier Damage in Psoriasis.

Sikora Mariusz, Stec Albert, Chrabaszcz Magdalena, Giebultowicz Joanna, Samborowska Emilia, Jazwiec Radoslaw, Dadlez Michal, Olszewska Malgorzata, Rudnicka Lidia

СтатьяПеревод в очереди

Аннотация

BACKGROUND

An increasing amount of evidence suggests an association between increased intestinal permeability and the pathogenesis of chronic inflammatory diseases. However, the clinical significance of gut barrier dysfunction in psoriasis remains to be established.

OBJECTIVE

To evaluate whether there are differences in disease activity, the severity of gastrointestinal symptoms and the blood concentration of bacterial metabolites in psoriatic patients with a normal and altered intestinal barrier.

PATIENTS AND

METHODS

Gut barrier integrity was assessed with the serum concentrations of claudin-3, a modulator of intestinal tight junctions and an intestinal fatty acid-binding protein, a marker of enterocyte damage. Gastrointestinal symptoms were evaluated with a validated questionnaire. The concentration of trimethylamine N-oxide (TMAO), a gut microbiota-associated metabolite, was measured with high-performance liquid chromatography.

RESULTS

One hundred and fourteen patients with psoriasis were finally enrolled in the study - 68 with an altered gut barrier and 46 with a properly functioning intestinal barrier. Patients with an altered gut barrier showed a significantly higher score in the Gastrointestinal Symptom Rating Scale (3.20 vs 1.46, p<0.001). Moreover, patients with psoriasis and a disrupted intestinal barrier demonstrated a higher disease activity (PASI: 19.7 vs 10.3, p<0.001) and systemic inflammatory parameters (neutrophil-to-lymphocyte ratio: 2.86 vs 1.71, p<0.001; C-reactive protein 3.76 vs 1.92; p<0.05). The marker of bacterial translocation was significantly higher in psoriatic patients with damaged gut integrity (TMAO: 375.7±51.9 vs 119.4±27.5 ng/mL; p<0.05).

CONCLUSION

The altered gut barrier in psoriasis is associated with gastrointestinal symptoms, systemic inflammatory profile and the increased blood concentration of gut microbiota-derived metabolite - TMAO. Intestinal barrier modulation represents a new promising therapeutic approach.

Для цитирования: Sikora Mariusz, Stec Albert, Chrabaszcz Magdalena, Giebultowicz Joanna, Samborowska Emilia, Jazwiec Radoslaw, Dadlez Michal, Olszewska Malgorzata, Rudnicka Lidia. Clinical Implications of Intestinal Barrier Damage in Psoriasis.. Journal of inflammation research. 2021. DOI: 10.2147/jir.s292544.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.